Prevnar Archives
Vaccine narrows racial disparities in pneumococcal disease
Aug. 31, 2020—In a major public health success, the introduction of pneumococcal conjugate vaccine PCV13, or Prevnar 13, in 2010 in the United States is associated with reduction in socioeconomic disparities and the near elimination of Black-white-based racial disparities for invasive pneumococcal disease.
